Skip to content

The library now covers 173 peptides. Browse it

Skin, hair & aesthetics · blend vial · Four-peptide aesthetic/recovery blend

KLOW

GHK-Cu + KPV + TB-500 + BPC-157

NovaEvum 80 mg fill: 50 mg GHK-Cu, 10 mg KPV, 10 mg TB-500, 10 mg BPC-157. The science is those four compounds — copper-peptide skin work, α-MSH fragment inflammation, and two repair fragments.

Library entry →

  • Skin
  • Healing
  • Anti-inflammatory
Catalog fill
80 mg blend
Typical water
4 mL
Route
Subcutaneous
Cycle
4–6 weeks.
Approval
Sourced from GHK-Cu, KPV, TB-500, and BPC-157 entries.
Status
Blend of four research chemicals.
Evidence
See the four singles. The 80 mg fill has no independent trial.
Research score
60 / 100

Mechanism

GHK-Cu ECM/copper, KPV cytokine dampening, BPC-157 VEGF/NO, TB-500 actin migration — locked in one ratio.

Safety file

Copper-load and angiogenic caveats from GHK-Cu and BPC-157/TB-500 still apply. Do not add the singles on the same days.

  • Injection-site reactions
  • Skin irritation
  • Headache

Reconstitution

4 mL bacteriostatic water yields 20 mg/mL total. A 0.1 mL (10 unit) draw is 2 mg total peptide: 1.25 mg GHK-Cu and 0.25 mg of each of the other three.

Research amounts

Once daily.

StepAmountFrequencyNotes
Daily research draw2 mg totalOnce daily10 units from a 4 mL reconstitution
Smaller daily draw1 mg totalOnce daily5 units

Storage

Lyophilized
−20 °C freezer preferred; a refrigerator is also acceptable. Do not open a cold vial — wait 15–30 minutes so it does not sweat. Avoid freeze–thaw cycling.
After water
2–8 °C, dark, up to 45 days when mixed with bacteriostatic water. Mixed vials stay in their box. Sterile water (no preservative) is single-use.

Worksheet notes

  • The certificate of analysis is the record of the actual fill. This worksheet uses the labelled split.
  • Do not add extra BPC-157, TB-500, KPV, or GHK-Cu on top without subtracting what KLOW already contributes.
  • Bacteriostatic water: 20–25 °C. Do not refrigerate the diluent.
  • Amounts on this sheet are reconstitution math for the vial, not a recommendation.

Full protocol

Titration, schedule, and handling

The complete protocol for KLOW. Where it differs from the worksheet amounts above, the worksheet reflects the NovaEvum vial.

Reconstitution

Concentration by vial size and water volume
Vial3 mL water5 mL water
80 mg26.67 mg/mL16 mg/mL

KLOW is a blend (GHK-Cu, BPC-157, TB-500, KPV in a 5:1:1:1 ratio), so 80 mg is the combined weight. The vial is usually 3 mL but occasionally ships as 5 mL; use the fill that matches the vial you received. Filling to the top dilutes the GHK-Cu sting as much as the vial allows. The calculator works in total blend mg: since GHK-Cu is 5 of every 8 parts, a 2.5 mg GHK-Cu dose is 4 mg of total blend.

  1. Use bacteriostatic water as the diluent.
  2. Add the water slowly, letting it run down the inside wall of the vial rather than onto the powder.
  3. Swirl gently to mix, then leave it to dissolve. Do not shake.
  4. Give it a few minutes. The finished solution should be clear and colourless.
  5. A faint blue tint from the copper is normal.
  6. The solution should otherwise be clear once mixed.

Protocol

Route: Subcutaneous

How a blend is dosed

  • Like GLOW, dose KLOW by the GHK-Cu amount; the BPC-157, TB-500 and KPV follow in the 5:1:1:1 ratio
  • The common range is 1 mg to 2.5 mg of GHK-Cu per day, with around 2.5 mg typical during loading
  • At a 3 mL fill the GHK-Cu portion comes to about 16.7 mg/mL, so 1 mg of GHK-Cu is a 0.06 mL draw (6 units) and 2.5 mg is 0.15 mL (15 units)
  • These figures are for the usual 3 mL fill; with a 5 mL vial, recalculate the draws

Schedule

  • One subcutaneous injection daily, or 5 days on, 2 days off, rotating sites
  • Run an 8 to 12 week block, then 4 to 8 weeks off
  • Inject slowly to limit the GHK-Cu sting
  • KLOW adds KPV, so it leans more anti-inflammatory than GLOW

Dosing detail

  • Dose by GHK-Cu content, 1 mg to 2.5 mg daily, scaling the rest of the blend with it. Around 2.5 mg is common during loading.
  • Once daily, subcutaneous, sites rotated.
  • Inject slowly given the copper content.

Duration

  • Typically run 8 to 12 weeks, often 5 days on and 2 off (or daily loading then 3 times weekly), then 4 to 8 weeks off and reassess.

Notes

  • Adds KPV (an anti-inflammatory tripeptide) to the GLOW base of GHK-Cu, BPC-157 and TB-500.
  • Inject subcutaneously and rotate sites.
  • Inject slowly given the copper content.

Storage and handling

  • Keep the powdered (lyophilized) vial in a cool, dark place. Refrigerate it for longer-term storage before mixing.
  • Once reconstituted and refrigerated at 2–8 °C away from light, use the vial within 90 days.
  • Do not freeze a reconstituted vial, and keep it away from heat and sunlight.
  • If the solution turns cloudy, develops floating particles, or shows any other sign of degradation, stop using that vial.
  • A faint blue tint is normal because of the GHK-Cu in the blend, not a sign of degradation.